Open‐label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin‐naïve Asian patients with type 2 diabetes

By  

Journal Of Diabetes Investigation, Vol. 9, Iss. 1, 2018-01 ,pp. : 100-107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study

By  

Journal Of Diabetes Investigation, Vol. 9, Iss. 1, 2018-01 ,pp. : 91-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin combined with Chinese medicine improves glycemic outcome through multiple pathways in patients with type 2 diabetes mellitus

By  

Journal Of Diabetes Investigation, Vol. 6, Iss. 6, 2015-11 ,pp. : 708-715

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open‐label, multicenter study

By  

Journal Of Diabetes Investigation, Vol. 9, Iss. 1, 2018-01 ,pp. : 127-136

John Wiley & Sons Inc

Access to resources Recommend Favorite

The relationship between the frequency of self‐monitoring of blood glucose and glycemic control in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion or on multiple daily injections

By  

Journal Of Diabetes Investigation, Vol. 6, Iss. 6, 2015-11 ,pp. : 687-691

John Wiley & Sons Inc

Access to resources Recommend Favorite